GGrantIndex
← Leaderboards

Nancy J Boudreau

University Of California San Francisco

$4,862,627
Attributed
$5,543,972
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $739.6K · FY200514
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14

Funding mix

By agency

NIH$5,543,972 · 5

By mechanism

R01$3,720,063 · 3
P01$1,823,909 · 2

Top collaborators

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Vascular Endothelial Growth Factors

Research focus

Vascular Endothelial Growth FactorsAngiogenesisTissuesBlood VesselsIn VivoCellsExtracellular MatrixHomeobox GenesIntegrinsGenesHomeoboxTranscription FactorEndothelial CellsMouse ModelAngiogenic FactorOrganEphrin-A1MediatingPermeabilityComplexArchitectureMammary NeoplasmsBiological ModelsBehavior

Grant awards (24)

The Regulation of Tumor Progression by Endothelial HoxA5$301,641
R01 · FY2014 · CA · contact PI
The Regulation of Tumor Progression by Endothelial HoxA5$292,312
R01 · FY2013 · CA · contact PI
Control of ECM in AVM formation by hoeobox genes$131,553
P01 · FY2013 · NS · contact PI
The Regulation of Tumor Progression by Endothelial HoxA5$310,970
R01 · FY2012 · CA · contact PI
Improved Drug Delivery to Tumors Using Novel Tissue Perfusion Approaches$261,106
R01 · FY2012 · CA
Control of ECM in AVM formation by hoeobox genes$167,533
P01 · FY2012 · NS · contact PI
The Regulation of Tumor Progression by Endothelial HoxA5$310,970
R01 · FY2011 · CA · contact PI
Improved Drug Delivery to Tumors Using Novel Tissue Perfusion Approaches$248,513
R01 · FY2011 · CA
Control of ECM in AVM formation by hoeobox genes$149,242
P01 · FY2011 · NS · contact PI
The Regulation of Tumor Progression by Endothelial HoxA5$320,588
R01 · FY2010 · CA · contact PI
Improved Drug Delivery to Tumors Using Novel Tissue Perfusion Approaches$256,199
R01 · FY2010 · CA
Control of ECM in AVM formation by hoeobox genes$151,850
P01 · FY2010 · NS · contact PI
Improved Drug Delivery to Tumors Using Novel Tissue Perfusion Approaches$256,199
R01 · FY2009 · CA
Control of ECM in AVM formation by hoeobox genes$154,092
P01 · FY2009 · NS · contact PI
CONTROL OF ECM REMODELING IN BAVM BY HOMEOBOX GENES$213,397
P01 · FY2007 · NS · contact PI
CONTROL OF ECM REMODELING IN BAVM BY HOMEOBOX GENES$220,498
P01 · FY2006 · NS · contact PI
CONTROL OF ECM REMODELING IN BAVM BY HOMEOBOX GENES$215,353
P01 · FY2005 · NS
HOX GENES, EXTRACELLULAR MATRIX REMODELING/ANGIOGENESIS$232,313
R01 · FY2004 · CA
CONTROL OF ECM REMODELING IN BAVM BY HOMEOBOX GENES$211,968
P01 · FY2004 · NS
HOX GENES, EXTRACELLULAR MATRIX REMODELING/ANGIOGENESIS$232,313
R01 · FY2003 · CA
CONTROL OF ECM REMODELING IN BAVM BY HOMEOBOX GENES$208,423
P01 · FY2003 · NS
HOX GENES, EXTRACELLULAR MATRIX REMODELING/ANGIOGENESIS$232,313
R01 · FY2002 · CA
HOX GENES, EXTRACELLULAR MATRIX REMODELING/ANGIOGENESIS$232,313
R01 · FY2001 · CA
HOX GENES, EXTRACELLULAR MATRIX REMODELING/ANGIOGENESIS$232,313
R01 · FY2000 · CA